Van Herk Investments B.V. 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:12 pm Purchase | 2024-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Van Herk Investments B.V. | 11,461,995 10.900% | 3,291,741 (+40.29%) | Filing |
| 2024-02-14 06:08 am Purchase | 2024-02-09 | 13G | ProQR Therapeutics N.V. PRQR | Van Herk Investments B.V. | 8,170,254 10.100% | 1,024,035 (+14.33%) | Filing |
| 2024-02-09 06:37 am Purchase | 2023-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Van Herk Investments B.V. | 7,146,219 8.800% | 2,865,354 (+66.93%) | Filing |
| 2023-09-14 5:20 pm Purchase | 2023-09-11 | 13G | ProQR Therapeutics N.V. PRQR | Van Herk Investments B.V. | 4,280,865 5.300% | 4,280,865 (New Position) | Filing |